Kalies K U, Görlich D, Rapoport T A
Max-Delbrück-Center for Molecular Medicine, Federal Republic of Germany.
J Cell Biol. 1994 Aug;126(4):925-34. doi: 10.1083/jcb.126.4.925.
The cotranslational translocation of proteins across the ER membrane involves the tight binding of translating ribosomes to the membrane, presumably to ribosome receptors. The identity of the latter has been controversial. One putative receptor candidate is Sec61 alpha, a multi-spanning membrane protein that is associated with two additional membrane proteins (Sec61 beta and gamma) to form the Sec61p-complex. Other receptors of 34 and 180 kD have also been proposed on the basis of their ability to bind at low salt concentration ribosomes lacking nascent chains. We now show that the Sec61p-complex has also binding activity but that, at low salt conditions, it accounts for only one third of the total binding sites in proteoliposomes reconstituted from a detergent extract of ER membranes. Under these conditions, the assay has also limited specificity with respect to ribosomes. However, if the ribosome-binding assay is performed at physiological salt concentration, most of the unspecific binding is lost; the Sec61p-complex then accounts for the majority of specific ribosome-binding sites in reconstituted ER membranes. To study the membrane interaction of ribosomes participating in protein translocation, native rough microsomes were treated with proteases. The amount of membrane-bound ribosomes is only slightly reduced by protease treatment, consistent with the protease-resistance of Sec61 alpha which is shielded by these ribosomes. In contrast, p34 and p180 can be readily degraded, indicating that they are not essential for the membrane anchoring of ribosomes in protease-treated microsomes. These data provide further evidence that the Sec61p-complex is responsible for the membrane-anchoring of ribosomes during translocation and make it unlikely that p34 or p180 are essential for this process.
蛋白质跨内质网(ER)膜的共翻译转运涉及正在翻译的核糖体与膜的紧密结合,推测是与核糖体受体结合。后者的身份一直存在争议。一个假定的受体候选物是Sec61α,一种多次跨膜蛋白,它与另外两种膜蛋白(Sec61β和γ)结合形成Sec61p复合物。基于它们在低盐浓度下结合缺乏新生链的核糖体的能力,还提出了34kD和180kD的其他受体。我们现在表明,Sec61p复合物也具有结合活性,但在低盐条件下,它仅占从ER膜去污剂提取物重构的蛋白脂质体中总结合位点的三分之一。在这些条件下,该测定对核糖体的特异性也有限。然而,如果在生理盐浓度下进行核糖体结合测定,大多数非特异性结合会消失;然后Sec61p复合物占重构ER膜中大多数特异性核糖体结合位点。为了研究参与蛋白质转运的核糖体与膜的相互作用,用蛋白酶处理天然糙面微粒体。蛋白酶处理仅使膜结合核糖体的数量略有减少,这与被这些核糖体屏蔽的Sec61α对蛋白酶的抗性一致。相反,p34和p180很容易被降解,表明它们对于蛋白酶处理的微粒体中核糖体的膜锚定不是必需的。这些数据提供了进一步的证据,表明Sec61p复合物在转运过程中负责核糖体的膜锚定,并且使得p34或p180不太可能是该过程所必需的。